Similarly, incorporating immune CIs like Programmed cell death protein 1 (PD-1) on the surface of EVs has been found to improve immune evasion and enhance tumor targeting, opening new avenues for novel immunotherapies [93]. This evidence concerns the gene PDCD1 and neoplasm.